Press release
Anaphylaxis Treatment Market Report 2024 - Anaphylaxis Treatment Market Analysis, Growth And Insights
Anaphylaxis Treatment Market
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp
According to The Business Research Company's, The anaphylaxis treatment market size has grown strongly in recent years. It will grow from $5.73 billion in 2023 to $6.15 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing incidence of allergic reactions, wider recognition of anaphylaxis, increased availability of epinephrine auto-injectors, public awareness and education, healthcare professional training.
The anaphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $7.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to innovation in biologic therapies, customized treatment approaches, global efforts on food safety, patient empowerment and advocacy, enhanced emergency medical services. Major trends in the forecast period include auto-injectors innovation, telemedicine for anaphylaxis management, improved allergen immunotherapy, biometric wearables for allergen detection, collaborations in allergy research.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report
Market Drivers and Trends:
The rise in the prevalence of food allergies is expected to propel the growth of the anaphylaxis treatment market going forward. Food allergy refers to an immune reaction to proteins in food. Anaphylaxis treatment helps to prevent the progression of life-threatening allergic symptoms involving the skin, mucosal surface, respiratory compromise, hypotension, and end-organ dysfunction. For instance, in January 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2021, 31.8% of adults aged 18 and older reported having eczema, a seasonal allergy, or a food allergy. One-fourth (25.7%) of adults had a seasonal allergy, 6.2% had a food allergy, and 7.3% of individuals had eczema. Therefore, the rise in the prevalence of food allergies is driving the growth of the anaphylaxis treatment market.
Advancement in product development is a key trend gaining popularity in the anaphylaxis treatment market. Major companies operating in the anaphylaxis treatment market are advancing their products to sustain their position in the market. For instance, in April 2022, Aquestive Therapeutics Inc., a US-based pharmaceutical company, received Fast Track designation for AQST-109 for the treatment of severe allergic responses, including anaphylaxis, from the Food and Drug Administration. Aquestive is moving forward with the clinical testing of AQST-109, the first and only orally administered epinephrine product candidate that has demonstrated clinical outcomes equivalent to autoinjectors (such as EpiPen and Auvi-Q) for the treatment of allergic emergencies, including anaphylaxis.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Pfizer Inc., Merck & Co. Inc., Novartis International AG, Abbott Laboratories, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., MannKind Corporation, Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Bioprojet SCR, Adamis Pharmaceutical Corporation, Impax Laboratories LLC.
Anaphylaxis Treatment Market 2024 Key Insights:
• The anaphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $7.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.
• Surging Prevalence Of Food Allergies Sparks Accelerated Growth In The Anaphylaxis Treatment Market
• Advancements In Anaphylaxis Treatment Products Shape Market Dynamics
• North America was the largest region in the anaphylaxis treatment market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12105&type=smp
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anaphylaxis Treatment Market Report 2024 - Anaphylaxis Treatment Market Analysis, Growth And Insights here
News-ID: 3760714 • Views: …
More Releases from The Business research company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Anaphylaxis
Anaphylaxis Treatment Market Insights, Forecast to 2031
"Anaphylaxis Treatment Market 2024,"
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Anaphylaxis Treatment market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Anaphylaxis Treatment industry, providing stakeholders with a nuanced perspective on…
Anaphylaxis Treatment Market Trends, Size, Forecast 2024-2033
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Anaphylaxis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $7.97 billion In 2028 At…
Anaphylaxis Treatment Size Share and Forecast 2023
The global anaphylaxis treatment size was valued at USD 3,104.4 million in 2022 and is poised to grow at a significant CAGR of 8.9% during the forecast period 2023-29. The primary drivers of the expansion of the global anaphylaxis treatment market include the increasing incidence of allergies and anaphylaxis. In addition, increasing number of geriatric patients and increasing research and development activities is expected to boost the growth of anaphylaxis…
Anaphylaxis Treatment Market Business Opportunities Forecast To 2028
The research report "Anaphylaxis Treatment Market: By Drug Class (Adrenergic Agents (Epinephrine), Anti-Histamines, Others), By Route of Administration (Parenteral, Oral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography." The global anaphylaxis treatment market was valued at USD 4,878.89 million in 2021 and is anticipated to grow at a CAGR of 8.9% during the forecast period 2022-2028.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/global-anaphylaxis-treatment-market/ …
Anaphylaxis Treatment Market Segments And Key Trends 2018 to 2028(Anaphylaxis Tr …
The type of severe allergic reaction which may cause due to food, insect bites, latex or medications is known as anaphylaxis. Anaphylaxis is fast in the beginning and cause serious health problems and sometimes death. The symptoms of anaphylaxis include itchy rashes, vomiting, breath shortness, tongue or throat swelling, low blood pressure, and lightheadedness. These all symptoms may last for a minute to an hour and may typically come on…
Anaphylaxis Market worth $40 billion by 2024
Latest report on United States Anaphylaxis Market of 180 pages now added by a leading business intelligence provider to ReportsnReports.com database. Access Full Report with Table of Contents @ https://www.reportsnreports.com/reports/1820038-united-states-anaphylaxis-market-food-reaction-testing-by-food-sources-treatment-services-age-group-urban-rural-end-users.html.
Anaphylaxis or Anaphylactic reaction is a very rare type of reaction which is caused by Foods, Medicines, Insect strings, Latex etc. In this report, we have studied the Anaphylaxis reaction to foods. Anaphylaxis food reaction is a life threatening allergy…
